GGrantIndex
← Leaderboards

Jonine Lisa Bernstein

Mount Sinai School Of Medicine Of Nyu

$38,646,945
Attributed
$49,552,728
Total exposure
12
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$49,552,728 · 12

By mechanism

R01$38,039,780 · 8
U01$9,336,761 · 1
T32$1,297,165 · 1
R21$879,022 · 2

Top collaborators

Most similar at Mount Sinai School Of Medicine Of Nyu

Same institution · by research overlap

Others in their field

Top investigators on “Woman

Research focus

WomanRisk FactorsMalignant Breast NeoplasmBreast Cancer Risk FactorRadiationSamplingBaseVariantCancer RiskParticipantEpidemiologyGeneticContralateralBreastGenome Wide Association StudyResourcesClassificationJointsInsightMalignant NeoplasmsEnvironment Related CancerCancer ControlGenomicsHigh Risk

Grant awards (44)

The Genetic Epidemiology of Radiation-Associated Contralateral Breast Cancer$752,049
R01 · FY2025 · CA · contact PI
Oncology-focused Postdoctoral Training in Care Delivery and Symptom Science (OPTICS)$477,062
T32 · FY2025 · CA
Oncology-focused Postdoctoral Training in Care Delivery and Symptom Science (OPTICS)$557,680
T32 · FY2024 · CA
Characterizing germline and somatic alterations by glioma subtypes and clinical outcome$923,381
R01 · FY2023 · CA
Oncology-focused Postdoctoral Training in Care Delivery and Symptom Science (OPTICS)$262,423
T32 · FY2023 · CA
Characterizing germline and somatic alterations by glioma subtypes and clinical outcome$1,498,836
R01 · FY2022 · CA
Molecular pathoepidemiology of contralateral breast cancer$1,297,113
R01 · FY2022 · CA
Characterizing germline and somatic alterations by glioma subtypes and clinical outcome$1,529,801
R01 · FY2021 · CA
Radiotherapy-associated breast cancer: machine learning on genotypes to predict individualized risk$167,926
R21 · FY2021 · CA
Molecular pathoepidemiology of contralateral breast cancer$1
R01 · FY2021 · CA
Molecular pathoepidemiology of contralateral breast cancer$2,016,169
R01 · FY2020 · CA
Radiotherapy-associated breast cancer: machine learning on genotypes to predict individualized risk$293,870
R21 · FY2020 · CA
Characterizing germline and somatic alterations by glioma subtypes and clinical outcome$656,870
R01 · FY2019 · CA
Molecular pathoepidemiology of contralateral breast cancer$414,309
R01 · FY2019 · CA
Characterizing germline and somatic alterations by glioma subtypes and clinical outcome$402,608
R01 · FY2019 · CA
Molecular pathoepidemiology of contralateral breast cancer$1,850,931
R01 · FY2018 · CA
Molecular pathoepidemiology of contralateral breast cancer$1,438,154
R01 · FY2017 · CA
MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer$682,549
R01 · FY2016 · CA · contact PI
MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer$667,192
R01 · FY2015 · CA · contact PI
MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer$715,899
R01 · FY2014 · CA · contact PI
Mammographic Density and Risk of Contralateral Breast Cancer$520,559
R01 · FY2014 · CA · contact PI
Identification of Etiologically Distinct Sub-Types of Breast Cancer$186,502
R21 · FY2014 · CA
Genome-Wide Association Study of Radiation Exposure and Bilateral Breast Cancer$2,773,200
R01 · FY2013 · CA · contact PI
Mammographic Density and Risk of Contralateral Breast Cancer$546,559
R01 · FY2013 · CA · contact PI
Identification of Etiologically Distinct Sub-Types of Breast Cancer$230,724
R21 · FY2013 · CA
Genome-Wide Association Study of Radiation Exposure and Bilateral Breast Cancer$2,985,202
R01 · FY2012 · CA · contact PI
Mammographic Density and Risk of Contralateral Breast Cancer$597,697
R01 · FY2012 · CA · contact PI
Genome-Wide Association Study of Radiation Exposure and Bilateral Breast Cancer$3,057,405
R01 · FY2011 · CA · contact PI
Genome-Wide Association Study of Radiation Exposure and Bilateral Breast Cancer$3,262,968
R01 · FY2010 · CA · contact PI
Genome-Wide Association Study of Radiation Exposure and Bilateral Breast Cancer$3,562,856
R01 · FY2009 · CA · contact PI
Breast Cancer, Radiation and the ATM-CHEK2 Pathway$437,161
R01 · FY2008 · CA · contact PI
Breast Cancer, Radiation and the ATM-CHEK2 Pathway$416,842
R01 · FY2007 · CA · contact PI
Interaction of Radiation, BRCA1/2, and Breast Cancer$828,511
R01 · FY2006 · CA · contact PI
Breast Cancer, Radiation and the ATM-CHEK2 Pathway$473,378
R01 · FY2006 · CA · contact PI
Interaction of Radiation, BRCA1/2, and Breast Cancer$722,625
R01 · FY2005 · CA
Breast Cancer, Radiation and the ATM-CHEK2 Pathway$502,390
R01 · FY2005 · CA
Interaction of Radiation, BRCA1/2, and Breast Cancer$734,952
R01 · FY2004 · CA
BREAST CANCER, RADIATION EXPOSURE, AND THE ATM GENE$1,473,321
U01 · FY2003 · CA
Interaction of Radiation, BRCA1/2, and Breast Cancer$905,180
R01 · FY2003 · CA
BREAST CANCER, RADIATION EXPOSURE, AND THE ATM GENE$7,730
U01 · FY2003 · CA
BREAST CANCER, RADIATION EXPOSURE, AND THE ATM GENE$2,545,284
U01 · FY2002 · CA
Interaction of Radiation, BRCA1/2, and Breast Cancer$866,433
R01 · FY2002 · CA
BREAST CANCER, RADIATION EXPOSURE, AND THE ATM GENE$2,688,107
U01 · FY2001 · CA
BREAST CANCER, RADIATION EXPOSURE, AND THE ATM GENE$2,622,319
U01 · FY2000 · CA